论文部分内容阅读
一个年营业额50亿美元的制药公司,要想保持每年递增8％～10％的发展速度,必须每年推出22个新药(NCE)。 我国医药界短期行为盛行,如不根本改变观念,与国际医药差距将越拉越大。制药企业必须果断地实行战略转移,推行创新战略,才能走入世界市场。
A pharmaceutical company with a turnover of 5 billion U.S. dollars must maintain 22 new drugs (NCE) annually in order to maintain an annual growth rate of 8% to 10%. The short-term behavior of the Chinese medical community is prevalent. If we do not fundamentally change our concepts, the gap with international medicine will increase. Pharmaceutical companies must implement strategy transfer decisively and implement innovation strategies before they can enter the world market.